SHR-1210 plus GEMOX as first line treatment in biliary tract cancer: Results from a single-arm exploratory study.

Chen, XF; Wu, XF; Wu, H; Shao, QW; Zhu, FP; Qian, XF; Zhao, FJ; Sun, J; Wang, J; Han, GH; Zhu, DQ; Zhu, LQ; Shao, Y; Gu, YH; Li, XC; Shu, YQ

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):